Akt and p38 MAPK signaling pathways are not only linked to oxaliplatin resistance, they were also shown to be strongly involved in the resistance to irinotecan and 5-FU in colorectal cancer [30,32,34,35]. The gene discussed is AKT1; the disease is colorectal cancer.